Robert Ruben, MD
Gastroenterology · Somersworth, NHNPI 1457354565
Payments from drug & device makers
Across 371 payments — averaging $95.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$29K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$735
- Takeda Pharmaceuticals U.S.A., Inc.$645
- Johnson & Johnson$490
- Boston Scientific$457
- plus $3K from 29 others
Across 6 payments — averaging $5833.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$35K
What the payments were for
- Speaking & faculty fees$25,12571%
- Travel & lodging$2,8988%
- Food & beverage$7,44321%
- Education$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 38 | $28,882 |
| AbbVie(2 entities) | 116 | $1,785 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $735 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $645 |
| Johnson & Johnson | 19 | $490 |
| Boston Scientific | 7 | $457 |
| Gilead | 10 | $233 |
| Phathom Pharmaceuticals, Inc. | 6 | $205 |
| Merck | 15 | $199 |
| UCB, Inc. | 11 | $168 |
| Bristol Myers Squibb | 7 | $159 |
| Sanofi | 4 | $145 |
| Medtronic | 1 | $132 |
| Intercept Pharmaceuticals, Inc. | 8 | $129 |
| Ferring Pharmaceuticals Inc. | 8 | $123 |
| Shire North American Group Inc | 4 | $99 |
| Madrigal Pharmaceuticals | 3 | $98 |
| Ironwood Pharmaceuticals, Inc | 4 | $81 |
| Daiichi Sankyo Inc. | 4 | $78 |
| Amgen | 3 | $65 |
| Aimmune Therapeutics, Inc. | 2 | $62 |
| Nestle Healthcare Nutrition Inc. | 3 | $61 |
| Braintree Laboratories, Inc. | 3 | $60 |
| Exact Sciences | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $48 |
| Lilly USA, LLC | 2 | $47 |
| Ambu Inc. | 1 | $44 |
| Shionogi Inc | 2 | $39 |
| Redhill Biopharma Inc. | 2 | $35 |
| Ardelyx, Inc. | 1 | $34 |
| Celltrion USA Inc. | 1 | $23 |
| Organon | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Mauna Kea Technologies, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,522 in reported general payments places this provider in the 85th percentile of 91 gastroenterology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 11 | $1,015,610 |
| LinzessLinaclotide | 67 | $58,047 |
| CreonLipase/Protease/Amylase | 11 | $39,949 |
| Mesalamine | 44 | $20,532 |
| Dexlansoprazole DrDexlansoprazole | 15 | $6,462 |
| Pantoprazole Sodium | 368 | $6,350 |
| Ursodiol | 16 | $3,847 |
| Balsalazide Disodium | 13 | $3,504 |
| Dicyclomine Hcl | 121 | $3,375 |
| Omeprazole | 132 | $2,543 |
| Colestipol Hcl | 15 | $2,134 |
| Esomeprazole Magnesium | 37 | $1,754 |
| Rabeprazole Sodium | 23 | $1,587 |
| Mercaptopurine | 13 | $1,508 |
| Famotidine | 83 | $1,416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $645 | $1,015,61011 claims |
| AbbVieLinzess, Creon | $1,785 | $97,99678 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 91 gastroenterology providers in New Hampshire.
Other gastroenterology in Somersworth
- Roger EpsteinSomersworth$6K
- Aristotle DamianosSomersworth$6K
- Dalia Mahmoud Hassan ElaminSomersworth$2K
- Sukeerti KesarSomersworth$2K
- Jennifer LewisSomersworth$2K
- Sean LynchSomersworth$949
- William MaherSomersworth$712
- David FlavinSomersworth$606
- Corey SiegelLebanon$1.9M
- Lee KaplanLebanon$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.